Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Some patients must continue to take supplements or receive injections for life depending on the reason for the deficiency
Blocking myostatin removes the genetic ceiling on muscle fiber hypertrophy
Don't convert between mcg and IU unless you know your peptide's conversion factor
Studies have shown a link between low vitamin B12 levels and osteoporosis
US$ 25.41
US$ 25.94
US$ 20.68
US$ 28.90
US$ 24.20
US$ 22.66
US$ 26.88
US$ 29.64
US$ 22.99
US$ 25.25
US$ 27.24
